Pascal and Francis Bibliographic Databases

Help

Search results

Your search

cc.\*:("002B02M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 6510

  • Page / 261
Export

Selection :

  • and

Development of an Intravitreal Peptide (BQ123) Sustained Release System Based on Poly(2-Hydroxyoctanoic Acid) Aiming at a Retinal Vasodilator ResponseVEURINK, Marieke; MANGIORIS, Georgios; KAUFMANN, Béatrice et al.Journal of ocular pharmacology and therapeutics. 2014, Vol 30, Num 6, pp 517-523, issn 1080-7683, 7 p.Article

Intravitreal Administration of Dexamethasone-Loaded PLGA-TPGS Nanoparticles for the Treatment of Posterior Segment DiseasesCHENMING YANG; LIQIN JIANG; SIJIANG BU et al.Journal of biomedical nanotechnology (Print). 2013, Vol 9, Num 9, pp 1617-1623, issn 1550-7033, 7 p.Article

Nanotechnology in Corneal Neovascularization Therapy—A ReviewGONZALEZ, Lilian; LOZA, Raymond J; HAN, Kyu-Yeon et al.Journal of ocular pharmacology and therapeutics. 2013, Vol 29, Num 2, pp 124-134, issn 1080-7683, 11 p.Article

Ophtalmologie : Enrichir et mettre à jour à jour sa panoplie pour mieux soigner, le tri 2012 = Ophthalmology : 2012 updateLa Revue Prescrire. 2013, Vol 33, Num 351, pp 52-53, issn 0247-7750, 2 p.Article

rosuvastatine (CRESTOR°) chez certains enfants: Évaluée a minima (bis)La Revue Prescrire. 2012, Vol 32, Num 345, issn 0247-7750, p. 500Article

Cibles rétiniennes d'action des médicaments = Retinal drug targetsBEHAR-COHEN, F.Annales pharmaceutiques françaises. 2011, Vol 69, Num 2, pp 124-130, issn 0003-4509, 7 p.Article

Halogen substituents on the aromatic moiety of the tetracaine scaffold improve potency of cyclic nucleotide-gated channel blockKIRK, Sarah R; ANDRADE, Adriana L; MELICH, Kenneth et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 21, pp 6417-6419, issn 0960-894X, 3 p.Article

The development of benzimidazoles as selective rho kinase inhibitorsHAMPTON SESSIONS, E; SMOLINSKI, Michael; SCHRÖTER, Thomas et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 6, pp 1939-1943, issn 0960-894X, 5 p.Article

Water-soluble PDE4 inhibitors for the treatment of dry eyeGOVEK, Steven P; OSHIRO, Guy; LIAO, John C et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 9, pp 2928-2932, issn 0960-894X, 5 p.Article

Ophtalmologie : Enrichir sa panoplie pour mieux soigner : le tri 2009 = Ophthalmology : 2009 updateLa Revue Prescrire. 2010, Vol 30, Num 315, issn 0247-7750, p. 52Article

New prostaglandin derivative for glaucoma treatmentPERRINO, Elena; ULIVA, Caterina; LANZI, Cecilia et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 6, pp 1639-1642, issn 0960-894X, 4 p.Article

Carbonic anhydrase inhibitors : The X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitorsDI FIORE, Anna; PEDONE, Carlo; ANTEL, Jochen et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 8, pp 2669-2674, issn 0960-894X, 6 p.Article

The in vitro immunomodulatory activity of a synthetic brassinosteroid analogue would account for the improvement of herpetic stromal keratitis in miceMICHELINI, Flavia M; BERRA, Alejandro; ALCHE, Laura E et al.Journal of steroid biochemistry and molecular biology. 2008, Vol 108, Num 1-2, pp 164-170, issn 0960-0760, 7 p.Article

Ophtalmologie : Enrichir sa panoplie thérapeutique : bilan de l'année 2007 = Ophtalmology : 2007 updateLa Revue Prescrire. 2008, Vol 28, Num 291, pp 51-51, issn 0247-7750, 1 p.Article

Benzimidazole-and benzoxazole-based inhibitors of Rho kinaseHAMPTON SESSIONS, E; YAN YIN; SCHRÖTER, Thomas et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 24, pp 6390-6393, issn 0960-894X, 4 p.Article

Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activityZIXIA FENG; MOHAPATRA, Suchismita; KLIMKO, Peter G et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 11, pp 2998-3002, issn 0960-894X, 5 p.Article

Combination Therapy for Choroidal NeovascularisationAUGUSTIN, Albert J; OFFERMANN, Indre.Drugs & aging. 2007, Vol 24, Num 12, pp 979-990, issn 1170-229X, 12 p.Article

Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1 : An experimental studyLABEE, Antoine; PAULY, Aude; HONG HANG et al.Journal of ocular pharmacology and therapeutics. 2006, Vol 22, Num 4, pp 267-278, issn 1080-7683, 12 p.Article

Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl α-ketoamide derivatives containing pyridine moietySHIRASAKI, Yoshihisa; MIYASHITA, Hiroyuki; YAMAGUCHI, Masazumi et al.Bioorganic & medicinal chemistry. 2006, Vol 14, Num 16, pp 5691-5698, issn 0968-0896, 8 p.Article

Ketorolac during the induction phase of cyclosporin-A therapySCHECHTER, Barry A.Journal of ocular pharmacology and therapeutics. 2006, Vol 22, Num 2, pp 150-154, issn 1080-7683, 5 p.Article

Evidence-based review of moxifloxacinO'BRIEN, Terrence P.International ophthalmology clinics. 2006, Vol 46, Num 4, pp 61-72, issn 0020-8167, 12 p.Article

The pharmacologic and pathophysiologic rationale for using nsaids in ocular inflammatory disease and ocular surgeryLINDSTROM, Richard.International ophthalmology clinics. 2006, Vol 46, Num 4, pp 7-11, issn 0020-8167, 5 p.Article

Ocular hypotensive effects of an intratracheally delivered liposomal Δ9-tetrahydrocannabinol preparation in ratsSZCZESNIAK, Anna-Maria; KELLY, Melanie E. M; WHYNOT, Sara et al.Journal of ocular pharmacology and therapeutics. 2006, Vol 22, Num 3, pp 160-167, issn 1080-7683, 8 p.Article

The effect of unoprostone isopropyl on Ca2+ release-activated Ca2+ currents in cultured monkey trabecular meshwork cells and ciliary muscle cellsSHIMURA, Masahiko; YASUDA, Kanako; NAKZAWA, Toru et al.Journal of ocular pharmacology and therapeutics. 2006, Vol 22, Num 4, pp 219-226, issn 1080-7683, 8 p.Article

Pegaptanib (Macugen°) : Dans la dégénérescence maculaire trop de risques pour trop peu de bénéfices = Pegaptanib for macular degenerationLa Revue Prescrire. 2006, Vol 26, Num 272, pp 333-333, issn 0247-7750, 1 p.Article

  • Page / 261